OptimizeRx Corp — Director's Dealing 2025

Oct 7, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2025-08-21

Reporting Person: D'Silva Andrew J. (Chief Business Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	37097	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$7.20	2029-10-01	Common Stock (6993)		Direct
Stock Option	$67.31	2026-08-31	Common Stock (40000)		Direct
Stock Option	$15.04	2027-10-02	Common Stock (13018)		Direct
Stock Option	$12.73	2028-12-19	Common Stock (5892)		Direct
Stock Option	$4.95	2029-12-11	Common Stock (13723)		Direct

Footnotes

F1: Includes 24,890 shares of common stock underlying unvested restricted stock units ("RSUs") granted under OPRX's equity incentive plans. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of OPRX common stock. The RSUs vest as follows: (i) 8,000 RSUs which represent the 4th and 5th installments of Mr. D'Silva's 9/1/2021 grant, these installments vest ratably on 9/1/2025 and 9/1/2026; (ii) 2,217 RSUs which represent the final installment of Mr. D'Silva's 10/3/2022 grant, which installment vests on 10/3/2025; (iii) 3,928 RSUs which represent the 3rd and 4th installments of Mr. D'Silva's 12/19/2023 grant, which installments vest ratably on 12/19/2025 and 12/19/2026; (iv) 3,472 RSUs which will vest in 3 equal annual installments beginning on 10/1/2025, which is the 1st anniversary of the grant date; and (v) 7,273 RSUs which will vest in three equal annual installments beginning on 12/11/2025, which is the 1st anniversary of the grant date.

F2: The stock option vests in three equal annual installments beginning October 1, 2025, which was the first anniversary of the grant date.

F3: The stock option vests in three equal annual installments beginning September 1, 2022, which was the first anniversary of the grant date.

F4: The stock option vests in three equal annual installments beginning October 3, 2023, which was the first anniversary of the grant date.

F5: The stock option vests in three equal annual installments beginning December 19, 2023, which was the first anniversary of the grant date.

F6: The stock option vests in three equal annual installments beginning December 11, 2024, which was the first anniversary of the grant date.